261 related articles for article (PubMed ID: 26108969)
1. Population-based trends in prenatal screening and diagnosis for aneuploidy: a retrospective analysis of 38 years of state-wide data.
Hui L; Muggli EE; Halliday JL
BJOG; 2016 Jan; 123(1):90-7. PubMed ID: 26108969
[TBL] [Abstract][Full Text] [Related]
2. Non-invasive prenatal testing for aneuploidy: current status and future prospects.
Benn P; Cuckle H; Pergament E
Ultrasound Obstet Gynecol; 2013 Jul; 42(1):15-33. PubMed ID: 23765643
[TBL] [Abstract][Full Text] [Related]
3. Population-based trends in invasive prenatal diagnosis for ultrasound-based indications: two decades of change from 1994 to 2016.
Lostchuck E; Poulton A; Halliday J; Hui L
Ultrasound Obstet Gynecol; 2019 Apr; 53(4):503-511. PubMed ID: 29877030
[TBL] [Abstract][Full Text] [Related]
4. Prenatal diagnostic testing and atypical chromosome abnormalities following combined first-trimester screening: implications for contingent models of non-invasive prenatal testing.
Lindquist A; Poulton A; Halliday J; Hui L
Ultrasound Obstet Gynecol; 2018 Apr; 51(4):487-492. PubMed ID: 29226487
[TBL] [Abstract][Full Text] [Related]
5. First trimester predictors of adverse pregnancy outcomes.
Brameld KJ; Dickinson JE; O'Leary P; Bower C; Goldblatt J; Hewitt B; Murch A; Stock R
Aust N Z J Obstet Gynaecol; 2008 Dec; 48(6):529-35. PubMed ID: 19133038
[TBL] [Abstract][Full Text] [Related]
6. Screening for trisomy 21 with maternal age, fetal nuchal translucency and maternal serum biochemistry at 11-14 weeks: a regional experience from Germany.
Soergel P; Pruggmayer M; Schwerdtfeger R; Muhlhaus K; Scharf A
Fetal Diagn Ther; 2006; 21(3):264-8. PubMed ID: 16601335
[TBL] [Abstract][Full Text] [Related]
7. National screening guidelines and developments in prenatal diagnoses and live births of Down syndrome in 1973-2016 in Denmark.
Lou S; Petersen OB; Jørgensen FS; Lund ICB; Kjaergaard S; ; Vogel I
Acta Obstet Gynecol Scand; 2018 Feb; 97(2):195-203. PubMed ID: 29194566
[TBL] [Abstract][Full Text] [Related]
8. First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics.
Kagan KO; Wright D; Spencer K; Molina FS; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 May; 31(5):493-502. PubMed ID: 18432600
[TBL] [Abstract][Full Text] [Related]
9. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.
Falcon O; Auer M; Gerovassili A; Spencer K; Nicolaides KH
Ultrasound Obstet Gynecol; 2006 Feb; 27(2):151-5. PubMed ID: 16388509
[TBL] [Abstract][Full Text] [Related]
10. [Value of detection of cell-free fetal DNA in maternal plasma in the prenatal diagnosis of chromosomal abnormalities].
Wang SJ; Gao ZY; Lu YP; Li YL; You YQ; Zhang LW; Wang LX; Xu H
Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):808-12. PubMed ID: 23302119
[TBL] [Abstract][Full Text] [Related]
11. Are age cutoffs still used to identify candidates for invasive testing for chromosomal abnormalities?
Wasden SW; Adams BN; Chasen ST
J Reprod Med; 2011; 56(3-4):113-6. PubMed ID: 21542527
[TBL] [Abstract][Full Text] [Related]
12. First-trimester biochemical markers of aneuploidy and the prediction of small-for-gestational age fetuses.
Spencer K; Cowans NJ; Avgidou K; Molina F; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Jan; 31(1):15-9. PubMed ID: 17999381
[TBL] [Abstract][Full Text] [Related]
13. Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination.
Dick PT
CMAJ; 1996 Feb; 154(4):465-79. PubMed ID: 8630836
[TBL] [Abstract][Full Text] [Related]
14. [Antenatal screening for Down syndrome: a smattering of epidemiology].
Boulvain M; Billieux MH; Irion O
Rev Med Suisse; 2008 Oct; 4(176):2276-8, 2280. PubMed ID: 19025178
[TBL] [Abstract][Full Text] [Related]
15. First-trimester screening for trisomy 21 using alpha-fetoprotein.
Bredaki FE; Wright D; Matos P; Syngelaki A; Nicolaides KH
Fetal Diagn Ther; 2011; 30(3):215-8. PubMed ID: 21952001
[TBL] [Abstract][Full Text] [Related]
16. Is nuchal translucency screening associated with different rates of invasive testing in an older obstetric population?
Chasen ST; McCullough LB; Chervenak FA
Am J Obstet Gynecol; 2004 Mar; 190(3):769-74. PubMed ID: 15042012
[TBL] [Abstract][Full Text] [Related]
17. Non-invasive chromosome test raises new questions in prenatal diagnosis about the significance of ultrasound and questions about new screening strategies.
Tercanli S; Vial Y; Merz E
Ultraschall Med; 2013 Oct; 34(5):417-20. PubMed ID: 24127381
[No Abstract] [Full Text] [Related]
18. First trimester screening for Down syndrome in multiple pregnancy.
Cleary-Goldman J; Berkowitz RL
Semin Perinatol; 2005 Dec; 29(6):395-400. PubMed ID: 16533653
[TBL] [Abstract][Full Text] [Related]
19. Declining invasive prenatal diagnostic procedures: A comparison of tertiary hospital and national data from 2012 to 2015.
Johnson K; Kelley J; Saxton V; Walker SP; Hui L
Aust N Z J Obstet Gynaecol; 2017 Apr; 57(2):152-156. PubMed ID: 28295165
[TBL] [Abstract][Full Text] [Related]
20. First- and second-trimester screening: detection of aneuploidies other than Down syndrome.
Breathnach FM; Malone FD; Lambert-Messerlian G; Cuckle HS; Porter TF; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Tripp T; Bianchi DW; D'Alton ME;
Obstet Gynecol; 2007 Sep; 110(3):651-7. PubMed ID: 17766613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]